Article
An “Omics” Approach to Determine the Mechanisms of Acquired Aromatase Inhibitor Resistance
20 Feb 2011
Abstract excerpt
Aromatase inhibitors (AIs) are the major types of drugs to treat hormone-dependent breast cancer. Although these drugs work effectively, cancer still recurs in many patients after treatment as a result of acquired resistance to the AIs. To characterize the resistant mechanisms, a set of MCF-7aro cell lines that acquired resistance to the AIs was generated. Through an "Omics" approach, we found that the resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
